AMBEX FIVE

Main information

  • Trade name:
  • AMBEX FIVE BROAD SPECTRUM WORMER FOR DOGS & CATS
  • Pharmaceutical form:
  • ORAL TABLET
  • Units in package:
  • 100Tab
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • BAYER AUSTRALIA

Documents

Localization

  • Available in:
  • AMBEX FIVE BROAD SPECTRUM WORMER FOR DOGS & CATS
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
  • Therapeutic area:
  • anthelmintic
  • Therapeutic indications:
  • HOOKWORM | HOOKWORM - ANCYLOSTOMA SPP. | ROUNDWORM | ROUNDWORM - TOXASCARIS LEONINA | TAPEWORM | ANCYLOSTOMA BRAZILIENSE | ANCYLOSTOMA CANINUM | ASCARID | DIPYLIDIUM CANINUM | HUMAN INTESTINAL ROUNDWORM | TAENIA HYDATIGENA | TAENIA OVIS | TAENIA PISIFORMIS | TAENIA SPP. | TOXOCARA MYSTAX | TOXOCARA SPP. | UNCINARIA STENOCEPHALA
  • Product summary:
  • For the control of roundworm, hookworm and tapeworms (except hydatid) in dogs and cats.Does not control heartworm or Hydatid tapeworms. Gastrointestinal upset may occur in rare cases. DO NOT OVERDOSE.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered but not available
  • Authorization number:
  • 36010/1200
  • Authorization date:
  • 05-01-2001
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Version Controlled Draft Label

AMBEX

FIVE

BROAD

SPECTRUM

WORMER FOR DOGS

&

CATS

Last Edited 18-12-00 11:50

pm

Page

of2

CAUTION

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

AMBEXFIVE

Broad Spectrum Wormer for Dogs & Cats

ACTIVE

CONSTITUENTS Each Tablet Contains.:

NICLOSAMIDE

500mg

&

LEVAMISOLE

BASE

21mg

(AS LEV

AMISOLE

HYDROCHLORIDE)

control

roundworms

(Toxocara

&

Toxascaris leonina),

hookworms

(Uncinaria stenocephala

&

Ancylostoma

spp) and tapeworms

(Taenia

&

Dipylidium caninum)

(excluding

Hydatids)

in dogs and cats.

Does

control

heartworm.

100 TABLETS

Registered to Bomac Laboratories

Distributed by Pharm Tech Pty Limited

DIRECTIONS FOR

DOSAGE AND ADMINISTRATION

Give one tablet per 5kg bodyweight before or with a small meal.

is recommended

that

tablets be crushed and added to food.

For kittens and

cats divide the dose,

giving

Y,

tablet per 5kg in

morning

repeating this 8-12 hours later.

OVERDOSE.

TREATMENT REGIMES

Roundworms

&

Hookworms (dogs)

Roundworms

&

Hookworms (cats)

Tapeworms (excluding hydatids) (cats and dogs)

Pregnant cats and dogs

APPROV~·~·~~

(TEXT)

Label

,;?I;;P.1Q.{9~

Date:

....

§..I..~

.....

.I':2

I....

t~~2~n..~_tu_re

_o~_o"_oof»._o._o~_oo_.oo_o~_.~_

_:.~-J0-

Treat at 2, 4, 8 and 12 weeks

age,

and thereafter every 12 weeks.

Treat at 6, 8 and 12 weeks

age,

and thereafter every 12 weeks.

Treat every 12 weeks.

Adequate

flea control should be maintained

year-round.

Treat at mating, before birth

kittens/puppies, then every 12

weeks.

Version Controlled Draft Label

AMBEX

FIVE

BROAD

SPECTRUM

WORMER FOR DOGS

&

CATS

Last Edited 18-12-00

1l:50

pm

Page

of2

Ifwonn

problems persist consult a Veterinary Surgeon.

Gastrointestinal upset may occur in rare cases.

First

Aid:

poisoning occurs contact a doctor

Poisons

Information

Centre.

Phone 131126.

Registered to Bomac Laboratories Limited.

Distributed by:

Phann Tech Pty Limited ACN 084 248 206

8 Apollo Avenue

West Pymble NSW 2073 Australia

Orders

&

Product Information Call 0500 886 668

DISPOSAL:

Dispose

empty container by wrapping with paper and placing in

garbage.

Storage:

Below

30

(Room Temperature) in a dry place.

NRA Approval No.

36010/~

l2CC:'

Batch Number:

Expiry Date:

30-11-2018

The European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSEs) in 2017

The European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSEs) in 2017

Published on: Thu, 29 Nov 2018 This report presents the results of surveillance on transmissible spongiform encephalopathies (TSEs) in bovine animals, sheep, goats, cervids and other animal species, as well as genotyping in sheep, carried out in 2017 in the European Union (EU) according to Regulation (EC) 999/2001, and in Iceland, Norway and Switzerland. In total, 1,312,714 cattle were tested by the 28 EU Member States (MSs) which is a decrease of 3% compared with 2016; 18,526 were tested by the three n...

Europe - EFSA - European Food Safety Authority Publications

17-11-2018

The Quaker Oats Company Issues Voluntary Recall of a Small Quantity of Cap’n Crunch’s Peanut Butter Crunch Cereal Distributed to Five Target Stores Due to Possible Health Risk

The Quaker Oats Company Issues Voluntary Recall of a Small Quantity of Cap’n Crunch’s Peanut Butter Crunch Cereal Distributed to Five Target Stores Due to Possible Health Risk

The Quaker Oats Company, a subsidiary of PepsiCo, Inc., today announced a voluntary recall of a small quantity of Cap’n Crunch’s Peanut Butter Crunch cereal due to the potential presence of Salmonella. While the potentially affected product only reached five specific Target stores and is limited to 21 boxes of one variety with two Best Before Dates, Quaker is initiating the voluntary recall to protect public health.

FDA - U.S. Food and Drug Administration

13-11-2018

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

On September 26, 2018 Oscor notified customers of a recall for certain lots (Recall No. 1035166- 09/07/2018-01-R) of TB Unshrouded Bipolar Pacing Leads. As part of the recall correction activities, Oscor is retrieving any remaining inventory out in the field. The recall scope is being expanded to include expired inventory for devices distributed between December 21, 2011 to May 17, 2018. The recall expansion is to ensure proper disposition of expired units. The FDA has been notified and is aware Oscor In...

FDA - U.S. Food and Drug Administration

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

27-9-2018

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

During the use of some TB - Temporary Bipolar Pacing Leads, featuring the 2mm unshrouded connectors, the connector cap housing (see Picture 1, No. 2 Pin Cap and Cover) may slide and potentially expose the connection wire. In some instances, this may cause the wire to be more susceptible to loss of connectivity or breakage during movement of the cables causing interruption of the pacing system. The analysis of the returned devices attributed the failure to a design change of the cap housing of the pins. ...

FDA - U.S. Food and Drug Administration

23-11-2018

.@US_FDA issues Class I Medical Device Recall, the most serious type of   recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to  Connector Separation Causing Potential for Loss of Pacing. Find out  more:  https://go.usa.gov/xPHxF  #FDA #MedicalDe

.@US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDe

. @US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDevice pic.twitter.com/negJ6HU4x2

FDA - U.S. Food and Drug Administration